GnuBio Unveils Sequencer at Consumer Genetics Conference, Reports Zero Error Rate in Internal Tests | GenomeWeb

At the Consumer Genetics Conference last week in Boston, GnuBio unveiled its $50,000 desktop sequencer, which recently shipped to the first of the company's beta testers ahead of a wider commercial launch of the system expected next year.

GnuBio CEO John Boyce announced at the opening of the conference that a planned live demonstration of the instrument had been cancelled due to issues with conference site regulators concerning the use of live biologic materials.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.